Nasdaq
ADPT
Adaptive Biotechnologies Corporation
- Health Care
- Listed 2019
- 1 day
- −4.1%
- 1 month
- +13.4%
- 1 year
- +102%
$23.60 · Mkt cap $3.77B
At the 6 Aug 2026 close
Nasdaq
Adaptive Biotechnologies Corporation
$23.60 · Mkt cap $3.77B
At the 6 Aug 2026 close
Adaptive Biotechnologies Corporation trades under the ticker ADPT on Nasdaq, in the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)). It has been listed since 2019. Its market capitalisation is $3.77B. The last closing price was $23.60, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +102%, and +13.4% over the past month. Returns are price returns and exclude dividends.
This page exists because ADPT is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.